Dana S Hardin
Overview
Explore the profile of Dana S Hardin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
767
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siegel A, Daneshkhah A, Hardin D, Shrestha S, Varahramyan K, Agarwal M
J Breath Res
. 2017 Jun;
11(2):026007.
PMID: 28569238
Diabetes is a disease that involves dysregulation of metabolic processes. Patients with type 1 diabetes (T1D) require insulin injections and measured food intake to maintain clinical stability, manually tracking their...
2.
Reich K, Leonardi C, Langley R, Warren R, Bachelez H, Romiti R, et al.
J Am Acad Dermatol
. 2016 Dec;
76(3):441-448.e2.
PMID: 28027825
Background: Inflammatory bowel disease (IBD) occurs more frequently in patients with psoriasis. The 2 diseases have significant genetic overlap, but the pathogenesis underlying their co-occurrence is unknown. Objective: We sought...
3.
Gordon K, Colombel J, Hardin D
N Engl J Med
. 2016 Dec;
375(21):2102.
PMID: 27959738
No abstract available.
4.
Dogs Can Be Successfully Trained to Alert to Hypoglycemia Samples from Patients with Type 1 Diabetes
Hardin D, Anderson W, Cattet J
Diabetes Ther
. 2015 Oct;
6(4):509-517.
PMID: 26440208
Introduction: Hypoglycemia (Hypo) is the most common side effect of insulin therapy in people with type 1 diabetes (T1D). Over time, patients with T1D become unaware of signs and symptoms...
5.
Cattet J, Hardin D
Diabetes Forecast
. 2015 Jan;
67(11):28, 30.
PMID: 25571753
No abstract available.
6.
Davidson J, Wolffenbuttel B, Arakaki R, Caballero A, Jiang H, Hardin D
Ethn Dis
. 2014 Jan;
23(4):393-400.
PMID: 24392599
Objective: To explore the impact of race/ethnicity on efficacy and safety of twice-daily insulin lispro mix 75/25 (LM75/25; 75% lispro protamine suspension, 25% insulin lispro) and once daily insulin glargine...
7.
Jovanovic L, Peters A, Jiang H, Hardin D
Aging Clin Exp Res
. 2013 Oct;
26(2):115-21.
PMID: 24092662
Background And Aims: Few studies have evaluated long-term durability of glycemic control in older patients. The aim of this study was to compare durability of glycemic control of twice-daily insulin...
8.
Wolffenbuttel B, Herman W, Gross J, Dharmalingam M, Jiang H, Hardin D
Diabetes Care
. 2013 Jun;
36(10):2931-6.
PMID: 23757434
Objective: Recent studies have reported hemoglobin A1c (HbA1c) differences across ethnic groups that could limit its use in clinical practice. The authors of the A1C-Derived Average Glucose study have advocated...
9.
Hardin D, Rohwer R, Curtis B, Zagar A, Chen L, Boye K, et al.
J Diabetes Sci Technol
. 2013 Apr;
7(2):420-30.
PMID: 23567001
Background: Treatment response in patients with type 2 diabetes mellitus (T2DM) varies because of different genotypic and phenotypic characteristics. Results of clinical trials are based largely on aggregated estimates of...
10.
Chisolm D, Hardin D, McCoy K, Johnson L, McAlearney A, Gardner W
Telemed J E Health
. 2011 Sep;
17(9):676-82.
PMID: 21943161
Objective: This study measured health literacy in a population of teens in treatment for asthma or diabetes and tested the association between health literacy and willingness to use online health...